Evaluation the efficacy of the probiotic (Ramnuflor and sabular) on acute diarrhea in six months to five –year- old children referred to Heshmatieh Hospital.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210312050687N1

Enrollment

180

Registered

2021-05-14

Start date

2021-04-21

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute diarrhea.

Interventions

Intervention 1: Intervention group: Group one. Group of children 6 months to 2 years receiving probiotic rhamnofluor. 45 people. This group receives standard ORS and Zinc fluid therapy along with 5

Eligibility

Sex/Gender

All

Age

6 Months to 5 Years

Inclusion criteria

Inclusion criteria: Clinical and laboratory symptoms based on chronic diarrhea. Diarrhea lasted more than 7 days. Be over 5 years old or under 6 months old The patient has a known case of immunodeficiency or cancer or a known underlying disease. Have an FTT or have a known chronic illness. Weight less than 3% percentile The patient has been taking probiotics for the past week Diarrhea accompanied by involvement or infection of other examined organs. Severe electrolyte disturbances such as hypernatremia, sodium betasherazine 145 and hypocalcemia, potassium less than 3.5 Dehydration percentage more than 10%

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of times diarrhea per day. Timepoint: For 7 days in a row. Method of measurement: interview.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi jalili akbarian

Heshmatieh Hospital sabzevar

jalilim56@yahoo.com+98 51 4401 1600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026